Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukaemia Relapse”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01175785
What this trial is testing

Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+17 more
Nohla Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00520208
What this trial is testing

Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL

Who this might be right for
Acute Promyelocytic Leukemia
CytRx 15
Early research (Phase 1)Study completedNCT00040950
What this trial is testing

Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01131247
What this trial is testing

PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & Ofatumumab

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
Nevada Cancer Institute 37
Early research (Phase 1)UnknownNCT04289220
What this trial is testing

Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia

Who this might be right for
B Cell LymphomaB-cell Acute Lymphoblastic Leukemia
Yan'an Affiliated Hospital of Kunming Medical University 10
Testing effectiveness (Phase 2)Study completedNCT04883749
What this trial is testing

Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL

Who this might be right for
Chronic Lymphoid Leukemia
German CLL Study Group 53
Testing effectiveness (Phase 2)Ended earlyNCT04730349
What this trial is testing

Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer

Who this might be right for
EpendymomaEwing SarcomaHigh-grade Glioma+7 more
Bristol-Myers Squibb 15
Testing effectiveness (Phase 2)Study completedNCT00049179
What this trial is testing

S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 33
Early research (Phase 1)Study completedNCT00064233
What this trial is testing

BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate

Who this might be right for
Leukemia
Jonsson Comprehensive Cancer Center 42
Not applicableLooking for participantsNCT05809284
What this trial is testing

Determining the Mechanisms of Loss of CAR T Cell Persistence

Who this might be right for
Acute Lymphoblastic Leukemia With Failed RemissionAcute Lymphoblastic Leukemia Not Having Achieved RemissionAcute Lymphoblastic Leukemia, Pediatric+2 more
University College, London 50
Testing effectiveness (Phase 2)UnknownNCT03265106
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects

Who this might be right for
Relapsed B-cell Acute Lymphoblastic Leukemia, ChildhoodRefractory B-cell Acute Lymphoblastic Leukemia, ChildhoodRelapsed/Refractory B-cell Lymphoma, Childhood
Shenzhen BinDeBio Ltd. 20
Early research (Phase 1)Study completedNCT02040506
What this trial is testing

A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AML

Who this might be right for
Acute Myelogenous LeukemiaAcute Myeloid Leukemia
Igenica Biotherapeutics, Inc. 19
Very early researchLooking for participantsNCT07695012
What this trial is testing

CAR-T Cell Therapy for ALL

Who this might be right for
Relapsed Acute Lymphoblastic Leukemia (ALL)
Dr. Zaineb Akram 10
Not applicableNot Yet RecruitingNCT07319793
What this trial is testing

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes (MDS)
Peking University People's Hospital 200
Very early researchLooking for participantsNCT06201247
What this trial is testing

Off-the-shelf CD123 CAR-NK for R/R AML

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory
Peking University People's Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00548847
What this trial is testing

Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation

Who this might be right for
Leukemia
Emory University 15
Testing effectiveness (Phase 2)Ended earlyNCT05086315
What this trial is testing

First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Acute Lymphocytic LeukaemiaAcute Myeloid Leukaemia RefractoryMyelodysplastic Syndromes+1 more
Sanofi 101
Testing effectiveness (Phase 2)Ended earlyNCT04849910
What this trial is testing

Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Vor Biopharma 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT02932280
What this trial is testing

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

Who this might be right for
Solid TumorCentral Nervous System TumorLymphoma+1 more
Memorial Sloan Kettering Cancer Center 14
Early research (Phase 1)Ended earlyNCT00098488
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaProlymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
National Cancer Institute (NCI) 30
Next Page